探索来自天然宏环法基利斯塔13的循环基抗瘤剂的潜力
Tong Li1, Shitian Jiang1, Tingting Li1
1Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin 150025, China.
Journal of medicinal chemistry
|July 11, 2024
概括
研究人员修改了Phakellistatin 13,一种天然环,以创造新的抗癌药物. 一种经过修改的环胺通过抑制瘤生长和诱导细胞死亡,显示出对抗肝癌的前途.
科学领域:
- 海洋天然产品化学 海洋天然产品化学
- 药品化学 药品化学 是一个
- 癌症生物学 癌症生物学
背景情况:
- 天然环酸,如海绵中的Phakellistatin 13,是新型抗癌药物的来源.
- 由于对这些天然化合物的探索,宏环制药正在取得进展.
- 帕克利斯塔丁13具有显著的抗瘤活性,这促使进一步调查.
研究的目的:
- 设计和合成基于Phakellistatin 13的新型性环.
- 为了研究结构受约束的环酸作为抗瘤剂的潜力.
- 通过结合isoindolinone部分来探索结构-活性关系.
主要方法:
- 改性环的化学合成,其中包含异印.
- 对抗瘤活性合成化合物的生物评估.
- 涉及细胞增殖,细胞亡,自和细胞周期分析的机制研究.
主要成果:
- 环3与交替的l-/d-氨基酸残留物显示出有前途的抗肝细胞癌效应.
- 帕克利斯塔丁13类类似物抑制了瘤细胞的增殖,并诱导了亡和自.
- 这些化合物通过调节p53和基激活蛋白激酶 (MAPK) 信号通路导致细胞循环停止.
结论:
- 由Phakellistatin 13衍生而来的形状受约束环是潜在的抗癌剂.
- 结构修改可以增强天然环酸的抗瘤功效.
- 了解分子机制为开发新的海洋制药提供了洞察力.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


